
Watch, listen, and make treatment decisions as Eric S. Daar, MD, leads you through a series of interactive clinical scenarios exploring the use of the newly approved antiretroviral agents in virologically suppressive regimens for treatment-experienced patients.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss key principles for maximizing the rates of virologic suppression in treatment-experienced patients
- Summarize the results of clinical studies that have evaluated the use of new antiretroviral agents in treatment-experienced patients
- Describe evidence-based strategies for selecting individualized regimens for treatment-experienced patients